Fungal cultures in minimal medium containing hydroquinone were incubated at several times to ensure different degradation yields. Fungal mycelium was then separated by centrifugation and the supernatants

buffered to pH 7.4 and isotonic conditions. Those samples obtained after fungal treatment (AFT) were then added to selleck inhibitor the fibroblast and HCT116 cells growing in McCoýs medium ( Fig. 2). Cell survival was evaluated by a well-established method based on the fluorescent conversion of a redox indicator (Alamar Blue®) after 24 h of culture on AFT samples. Controls were provided by fibroblasts and HCT116 cells cultivated exactly for the same periods of time in plain MMFe medium i.e. in which the fraction of saline medium was freshly prepared without hydroquinone. The data shows a strong correlation between higher remaining concentrations of hydroquinone and reduced survival of HCT116 cells ( Fig. 2). A different survival pattern was observed on fibroblasts; data depicted in Fig. 2 shows that concentrations of 33.6 μM of hydroquinone obtained after fungal treatment can reduce approximately 70% of the survival of fibroblasts cells. These data suggests that P. chrysogenum TSA HDAC clinical trial var. halophenolicum produces one

or more metabolites during hydroquinone degradation that increase its toxicity, in particularly to fibroblasts cells. On the other hand, the salt medium composition (controls) did not affect cell viability. To further address whether hydroquinone itself did play the key role in reduced survival of human cells, we cultivated HCT116 cells in medium in which hydroquinone had been reduced to undetectable levels by P. chrysogenum from initial concentrations

of 4541 or 7265 μM ( Fig. 3). The results show that, irrespectively of the initial concentration of hydroquinone, survival of HCT116 cells is only minimally affected when compared to controls cultured in freshly prepared salt medium ( Fig. 2 and Fig. 3). Importantly, when purified hydroquinone was added back to a final concentration of 227 μM, survival of HCT116 cells were reduced to levels comparable to those observed when hydroquinone reached similar concentrations via P. chrysogenum-dependent degradation ( Fig. 2 and Fig. 3). Together, these data demonstrate that P. chrysogenum Benzatropine var. halophenolicum is able to reduce the toxicity exerted by hydroquinone on cultured human cells. We subsequently tested whether the capacity P. chrysogenum to eliminate the negative effect of hydroquinone on fibroblasts and HCT116 cells observed previously, was due to the hydroquinone degradation to undetectable levels in culture. To do so, batch cultures with P. chrysogenum var. halophenolicum and hydroquinone at different initial concentrations of 4541 and 7265 μM in saline liquid media (MMFe) were performed. The results are shown in Fig. 4.